Monday, July 13, 2015 10:47:03 PM
I'm speculating, but feel fairly comfortable with my investment in this price range - especially when many of the larger raises in the past were done at > 60 cents.
Also, I'm not intimately familiar with One Equity Research, but they did a great write-up on the current state of FluoroPharma. Pretty accurate from what I can tell.
http://ir.baystreet.ca/article.aspx?id=136&1434538833
Is there still risk here? Absolutely! But in my opinion, the reward greatly outweighs the downside based on the current price per share. Time will tell. Management has been quiet, so I'm hoping there is urgency to get the train back on its track.
Just my two cents.
FEATURED POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI Systems • May 14, 2024 10:09 AM
FEATURED Element79 Gold Corp Reports Exceptionally High-Grade Results from Lucero • May 14, 2024 7:00 AM
VAYK Added New Manager for Expansion into $64 Billion Domestic Short-term Rental Market • VAYK • May 14, 2024 9:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM